Nathalie Garnier
- Genetics top 10%
- Hemoglobinopathies and Related Disorders 7
- Hematology top 10%
- Iron Metabolism and Disorders 5
- Clinical Biochemistry top 10%
-
- Viral-associated cancers and disorders 5
- Neutropenia and Cancer Infections 4
-
- Lymphoma Diagnosis and Treatment 9
-
- Acute Lymphoblastic Leukemia research 6
-
- Coronary Interventions and Diagnostics 4
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Yves BertrandC. RénardPhilippe ConnesDaniela CuzzubboPhilippe JolyCéline RenouxKamila KébaïliA. Martinot
- Journals
- Journal of Clinical Oncology (2 papers)Blood (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Nathalie Garnier
37 papers receiving 365 citations
Peers
Comparison fields: 5 of 68
- Genetics 117
- Hematology 116
- Clinical Biochemistry 41
- Internal Medicine 16
- Oncology 82
Countries citing papers authored by Nathalie Garnier
This map shows the geographic impact of Nathalie Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Garnier more than expected).
Fields of papers citing papers by Nathalie Garnier
This network shows the impact of papers produced by Nathalie Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Garnier. The network helps show where Nathalie Garnier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathalie Garnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 23 | |
| 13 | 2016 | 12 | |
| 14 | 2015 | 8 | |
| 15 | 2014 | 5 | |
| 16 | 2010 | 43 | |
| 17 | 2010 | 1 | |
| 18 | 2008 | 1 | |
| 19 | 2006 | 6 | |
| 20 | 1999 | 17 |
About Nathalie Garnier
Nathalie Garnier is a scholar working on Hematology, Genetics and Clinical Biochemistry, having authored 42 papers that have together received 373 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Hemoglobinopathies and Related Disorders (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Viral-associated cancers and disorders (5 papers), Iron Metabolism and Disorders (5 papers), Coronary Interventions and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Genetics (117 citations), Hematology (116 citations) and Clinical Biochemistry (41 citations). Nathalie Garnier has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Yves Bertrand, C. Rénard, Philippe Connes, Daniela Cuzzubbo, Philippe Joly, Céline Renoux, Kamila Kébaïli, A. Martinot, François Dubos and Françoise Mazingue. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.